MSD BRAVECTO CHEW SMALL x1

R212,87 excl.

For Small Dogs             (> 4,5 – 10 kg)
For the treatment and prevention of tick, flea and mite infestations in dogs. Bravecto® kills
adult, and juvenile ticks (larvae and nymphs). Bravecto® can be used as part of a treatment
strategy for flea allergy dermatitis (FAD). For the treatment of Demodicosis caused by
Demodex spp. and Sarcoptic mange mites.

Description

Reg. No. G4083 (Act 36/1947)

Namibia Reg. No. V14/18.3.10/1259 [NS0]

NAFDAC Reg. No. A9-100511, A9-100512, A9-100513, A9-100514, A9-100515

INDICATIONS

For the treatment and prevention of tick, flea and mite infestations in dogs. Bravecto® kills adult, and juvenile ticks (larvae and nymphs). Bravecto® can be used as part of a treatment strategy for flea allergy dermatitis (FAD). For the treatment of Demodicosis caused by Demodex spp. and Sarcoptic mange mites. In a controlled trial, treatment with fluralaner resulted in the complete removal of Demodex spp. mites from treated dogs.

For the treatment of Otodectes spp. ear mite infestations.

The flea insecticidal efficacy of Bravecto® (fluralaner) significantly reduces the likelihood of Dipylidium caninum (tapeworm) transmission from fleas to susceptible dogs throughout the 84 days following a single treatment, by controlling fleas on dogs and lowering the flea burden in the dog’s immediate environment.

COMPOSITION

Contains fluralaner equivalent to 25 to 56 mg/kg body weight.

Each chewable tablet contains:

Small Dogs:                    250 mg